Table 2

Univariate analysis of the overall survival in CVST patients

VariableHR95% CIP values
Age1.0461.020 to 1.072<0.001*
Gender0.7070.472 to 1.0600.093
From onset to admission time(t)0.9990.996 to 1.0020.530
Malignancy3.1420.952 to 10.3660.060
Infection1.2930.616 to 2.7180.497
Pregnancy or puerperium0.6050.211 to 1.7340.350
Haematological diseases2.0870.497 to 8.7660.315
Trauma1.4440.197 to 10.5990.718
Intracerebral haemorrhage2.7651.294 to 5.9100.009*
Epilepsy1.3240.568 to 3.0870.515
Dyskinesia and sensory disturbance1.3910.569 to 3.4040.469
Coma5.0592.470 to 10.362<0.001*
Barylalia1.0680.145 to 7.8400.948
Isolated headache0.0410 to 5.0330.193
Intracranial hypertension1.5380.629 to 3.7640.345
LMR0.6280.461 to 0.8570.003*
D-dimer1.0300.990 to 1.0720.141
Left sigmoid sinus0.4290.164 to 1.1220.084
Right sigmoid sinus0.7310.325 to 1.6410.447
Left transverse sinus1.0400.505 to 2.1420.914
Right transverse sinus1.1940.583 to 2.4470.627
Straight sinus4.2492.072 to 8.710<0.001*
Superior sagittal sinus1.2640.579 to 2.7610.556
Inferior sagittal sinus1.2610.440 to 3.6130.666
Venous1.5410.590 to 4.0250.377
  • *Statistically significant.

  • CVST, cerebral venous sinus thrombosis; LMR, lymphocyte to monocyte ratio.